Fed. Circ. Ruling May Affect Eligibility Of Life Sciences Patents
The U.S. Court of Appeals for the Federal Circuit's ruling in American Axle & Manufacturing Inc. v. Neapco Holdings LLC[1] last month might significantly impact patent eligibility for method-of-treatment and medical...To view the full article, register now.
Already a subscriber? Click here to view full article